
Corcept Therapeutics Incorporated CORT
€ 33.68
0.71%
Quartalsbericht 2025-Q3
hinzugefügt 04.11.2025
Corcept Therapeutics Incorporated P/CF 2011-2026 | CORT
P/CF Jährlich Corcept Therapeutics Incorporated
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 33.1 | 20 | 18.5 | 13.6 | 19.9 | 11 | 11.7 | 44.4 | 45 | 125 | -10.7 | -10 | -5.35 | -10.3 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 125 | -10.7 | 21.9 |
P/CF anderer Aktien in der Pharmaeinzelhändler
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M | ||
|
ARCA biopharma
ABIO
|
-8.36 | - | 1052.0 % | $ 415 M | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
-12.4 | $ 18.33 | -0.92 % | $ 2.7 B | ||
|
Amgen
AMGN
|
13.6 | $ 343.48 | 0.47 % | $ 184 B | ||
|
Arrowhead Pharmaceuticals
ARWR
|
34.8 | $ 72.81 | 5.02 % | $ 9.74 B | ||
|
I-Mab
IMAB
|
-0.266 | - | - | $ 866 M | ||
|
Aytu BioScience
AYTU
|
-8.14 | $ 2.72 | 4.62 % | $ 17.1 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | ||
|
Adagene
ADAG
|
-2.96 | $ 2.99 | 8.55 % | $ 168 M | ||
|
Biogen
BIIB
|
6.73 | $ 177.96 | -1.07 % | $ 25.9 B | ||
|
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M | ||
|
Midatech Pharma plc
MTP
|
-13.2 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | ||
|
Akero Therapeutics
AKRO
|
-14.1 | - | - | $ 3.67 B | ||
|
Alterity Therapeutics Limited
ATHE
|
-94.9 | $ 3.12 | -1.74 % | $ 7.51 B | ||
|
Acorda Therapeutics
ACOR
|
-1.2 | - | -24.86 % | $ 820 K | ||
|
Aptose Biosciences
APTO
|
-0.0645 | - | -45.71 % | $ 1.2 M | ||
|
Acasti Pharma
ACST
|
-2.73 | - | 4.01 % | $ 150 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | ||
|
Akebia Therapeutics
AKBA
|
-11 | $ 1.4 | -0.71 % | $ 262 M | ||
|
Albireo Pharma
ALBO
|
-5 | - | -0.23 % | $ 916 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - | ||
|
Allena Pharmaceuticals
ALNA
|
-2.48 | - | 3.16 % | $ 1.9 M | ||
|
Ascendis Pharma A/S
ASND
|
-17.6 | $ 223.74 | -1.05 % | $ 5 B | ||
|
Ampio Pharmaceuticals
AMPE
|
-0.0776 | - | -11.43 % | $ 502 K | ||
|
Burford Capital Limited
BUR
|
11.6 | $ 9.85 | 1.65 % | $ 1.59 B | ||
|
Applied Molecular Transport
AMTI
|
-0.236 | - | - | $ 10.1 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-413 | $ 4.13 | 2.92 % | $ 8.99 B | ||
|
Aravive
ARAV
|
-0.928 | - | -13.39 % | $ 1.45 M | ||
|
BioNTech SE
BNTX
|
70.7 | $ 110.82 | -2.58 % | $ 27.2 B | ||
|
Athira Pharma
ATHA
|
-0.166 | - | - | $ 269 M | ||
|
Aeterna Zentaris
AEZS
|
-4.82 | - | 5.93 % | $ 314 M | ||
|
Autolus Therapeutics plc
AUTL
|
-2.05 | $ 1.39 | 1.09 % | $ 355 M | ||
|
AgeX Therapeutics
AGE
|
-0.0018 | - | -10.17 % | $ 12.2 K | ||
|
AVROBIO
AVRO
|
-0.891 | - | 1083.1 % | $ 745 M | ||
|
Cardiff Oncology
CRDF
|
-5.16 | $ 1.72 | -2.0 % | $ 82 M | ||
|
Akouos
AKUS
|
-2.7 | - | 0.23 % | $ 488 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
-14.6 | - | -15.15 % | $ 60.3 M | ||
|
Brickell Biotech
BBI
|
-2.62 | - | -5.38 % | $ 6.06 M | ||
|
Amneal Pharmaceuticals
AMRX
|
6.19 | $ 14.17 | 3.55 % | $ 4.38 B | ||
|
Compugen Ltd.
CGEN
|
2.98 | $ 1.85 | 0.27 % | $ 166 M | ||
|
AIkido Pharma
AIKI
|
-1.3 | - | 1.93 % | $ 17.4 M | ||
|
Atreca
BCEL
|
-0.607 | - | -11.76 % | $ 5.79 M | ||
|
CureVac N.V.
CVAC
|
-4.82 | - | - | $ 867 M | ||
|
Acer Therapeutics
ACER
|
-0.401 | - | 2.71 % | $ 14 M | ||
|
BioCryst Pharmaceuticals
BCRX
|
-33 | $ 6.68 | 1.52 % | $ 1.38 B | ||
|
Alpine Immune Sciences
ALPN
|
-6.14 | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
-0.723 | - | 4.14 % | $ 49.1 M | ||
|
Beam Therapeutics
BEAM
|
-7.21 | $ 28.17 | 1.99 % | $ 2.32 B | ||
|
BeiGene, Ltd.
BGNE
|
-1.8 K | - | 0.49 % | $ 251 B |